Subchapter 1 - REQUIREMENTS FOR PROVISION OF PHARMACEUTICAL SERVICES
- Section 10:167A-1.1 - Introduction
- Section 10:167A-1.2 - Definitions
- Section 10:167A-1.3 - Participation of eligible providers
- Section 10:167A-1.4 - Reserved
- Section 10:167A-1.5 - Conditions for participation as a provider of pharmaceutical service
- Section 10:167A-1.6 - Program restrictions affecting payment for prescribed drugs
- Section 10:167A-1.7 - Basis of payment
- Section 10:167A-1.8 - Reserved
- Section 10:167A-1.9 - Prescription drug dispensing fee
- Section 10:167A-1.10 - PAAD program copayment
- Section 10:167A-1.11 - Compounded prescriptions
- Section 10:167A-1.12 - Non-proprietary or generic dispensing
- Section 10:167A-1.13 - Provider$DQ$s usual and customary charge or advertised charge
- Section 10:167A-1.14 - Covered pharmaceutical services
- Section 10:167A-1.15 - Non-covered pharmaceutical services
- Section 10:167A-1.16 - Quantity of medication
- Section 10:167A-1.17 - Dosage and directions
- Section 10:167A-1.18 - Telephone-rendered, faxed or electronically transmitted original prescriptions
- Section 10:167A-1.19 - Changes or additions to the original prescription
- Section 10:167A-1.20 - Prescription refill
- Section 10:167A-1.21 - Prescription Drug Price and Quality Stabilization Act
- Section 10:167A-1.22 - Drug Efficacy Study Implementation (DESI)
- Section 10:167A-1.23 - Bundled drug service
- Section 10:167A-1.24 - Claim submission
- Section 10:167A-1.25 - Eligible PAAD beneficiary
- Section 10:167A-1.26 - PAAD beneficiary identification
- Section 10:167A-1.27 - Point-of-sale (POS) claims adjudication system
- Section 10:167A-1.28 - Prospective drug utilization review (PDUR) program
- Section 10:167A-1.29 - Medical exception process (MEP)
- Section 10:167A-1.30 - Drug rebate program